Winebrenner Capital Management’s First Trust Limited Duration Investment Grade Corporate ETF FSIG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$634K Sell
33,623
-3,870
-10% -$73.3K 0.39% 78
2026
Q1
$710K Hold
37,493
0.46% 67
2025
Q4
$719K Buy
37,493
+2,500
+7% +$48K 0.48% 63
2025
Q3
$672K Buy
34,993
+5,666
+19% +$109K 0.48% 66
2025
Q2
$561K Hold
29,327
0.45% 75
2025
Q1
$555K Sell
29,327
-1,318
-4% -$24.9K 0.5% 70
2024
Q4
$578K Buy
+30,645
New +$582K 0.45% 75

Other funds holding FSIG

Winebrenner Capital Management's FSIG Position: Q2 2026 in Review

Winebrenner Capital Management reduced its First Trust Limited Duration Investment Grade Corporate ETF (FSIG) stake by 10% in Q2 2026, selling an estimated $73.3K and leaving 33,623 shares worth $634K. The position accounts for 0.39% of the portfolio, ranked #78.

Winebrenner Capital Management first reported a position in FSIG in Q4 2024 and has held it in 7 quarters since. The position peaked at $719K in Q4 2025. 20 funds tracked by Wall St. Rank hold FSIG as of Q2 2026.

  • Winebrenner Capital Management held 33,623 shares of First Trust Limited Duration Investment Grade Corporate ETF worth $634K as of Q2 2026.
  • Winebrenner Capital Management sold 3,870 First Trust Limited Duration Investment Grade Corporate ETF shares in Q2 2026, an estimated $73.3K.
  • First Trust Limited Duration Investment Grade Corporate ETF made up 0.39% of Winebrenner Capital Management's portfolio in Q2 2026, its #78 holding.
  • Winebrenner Capital Management first reported a position in First Trust Limited Duration Investment Grade Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • Winebrenner Capital Management's First Trust Limited Duration Investment Grade Corporate ETF position peaked at $719K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held First Trust Limited Duration Investment Grade Corporate ETF as of Q2 2026.

Based on Winebrenner Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.